Octimet Oncology completes venture financing

On Jan. 19, cancer play Octimet Oncology N.V. (Beerse, Belgium) raised €11.3 million ($12 million) in a series A round co-led by V-Bio Ventures and Fund+. Droia Oncology Ventures and Omnes Capital al...